Mr. Mustafoglu is the founder and President of TransGlobal Financial
Corporation. Prior to establishing TransGlobal in 1991, Mr. Mustafoglu served
in executive positions with the Oxbow Group, which has been ranked by Forbes
magazine as one of the top 400 privately held companies in the United States.
The Oxbow group of companies has been engaged in private equity investing,
commodities trading, industrial manufacturing, electricity, oil and coal
production, petroleum refining, publishing and high technology. Mr. Mustafoglu
was instrumental in the startup, turnaround and development of various Oxbow
portfolio companies and served on the firm's Management Committee. He was
vice-president of Oxbow Resources, and President of the following companies:
Oxbow Energy, Inc., Pacific Basin Transportation, Inc., Oxbow Hydrocarbons,
Inc. and PetroPort Terminal Corporation.
Prior to joining Oxbow in 1984, Mr. Mustafoglu was with Getty Oil
Company of Los Angeles, where he had executive positions in corporate finance
and planning. His most recent position was Vice President of Finance for Getty
Oil Canada, a $600 million company. Prior
to joining Getty, he was with Shell Oil Company performing digital seismic
Mustafoglu serves as director on the boards of various public and private
companies. Some of these public companies included ECO2, Inc., Serv-Tech,
Inc., Corgenix Medical Corporation, U.S. Medical Group, Inc. and Para Mas
Mustafoglu received a Bachelor of Science degree in Electrical Engineering
from Wichita State University in Kansas in 1974, where he attended school as a
Fulbright Scholar. He earned a Masters in Business Administration in finance
and quantitative science from University of Southern California/University of
Houston in 1978. In 1990, Palm Beach Atlantic College awarded him the American
Free Enterprise Medal in recognition of his entrepreneurial accomplishments.
Mr. Mustafoglu is the author of various articles dealing with business risk.
Ms. Brancato has 18 years of progressive experience in corporate finance,
strategy and development. She has an MBA Degree in Finance and Marketing from
Harvard Business School where she was Godfrey Cabot Fellow and Herman
Muehlstein Foundation Scholar. She also has a B.A. degree in Psychovisual
Physics and Economics from Hunter College in New York. Ms. Brancato started
her career on Wall Street and has been a Financial Analyst with E.F. Hutton
and Company, Strategic Planning Officer at Banker Trust Company and Product
Manager, Futures and Options for Morgan Stanley and Company. She was a Senior
Consultant with McKinsey and Company where she consulted with major U.S.
investment banks. Ms. Brancato was also Vice President, Product Development
and Marketing for Equitable Capital Management Company where she structured
and launched proprietary investment products. She founded The Brancato-Fritsch
Company in New York City in 1990 to provide corporate advisory services and
act as interim CFO and COO for companies in transition. She developed and
launched a $500 million Internet Applications Software Provider for GTE,
devising marketing and strategic alliances; managed the united States investor
relations and capital raising efforts for a leading European oil company;
re-organized European sales and trading efforts for a major international
bank, resulting in a 35% increase in market share; served as interim manager
for a pension advisor's strategic consulting business, bringing in Brinson
Partners/UBS, Putnam, AMEX/IDS and Fidelity and schieving 400% revenue growth
in six months, leading to doubling of revenues in the second year. In 1999,
Ms. Brancato became actively involved in the New Economy companies and was
involved in a $25 million capital raise for a new Internet portal/TV network,
the launch of IncredibleArt.com, the launch of a $150 million Internet/film
fund and serving as CFO of Search by Media.com, WebMoney and IllusionWorks/CalTech.
Chittick is a highly regarded consultant for media affairs. He has helped
major corporations manage their media relations and publicity campaigns. He
has advised senior corporate executives how to successfully deal with
journalists ensuring that their corporate message was clearly and correctly
transmitted to the public. Mr. Chittick is also an expert in media training
and the use of communications as a strategic tool. Prior to joining
TransGlobal, Mr. Chittick had a highly successful and award winning career as
a network television journalist. For many years he was the senior West Coast
producer for ABC Network News. He has supervised teams of up to 100 writers,
correspondents, cameramen, editors and technicians. He directed coverage of
major news events for programs such as Night Line, 20/20, World News Tonight
with Peter Jennings and Good Morning America. Among his specialized coverage
areas were Technology, International Relations and Military Affairs. He
covered eight presidential elections, six wars and countless disasters. For
several years, he wrote a column on Interactive Entertainment for abcnews.com.
technology reporting focused on the growth of the Internet, the
expanding use of computers in the office and the home, multimedia
entertainment and social implications of the Internet.
Mr. Chittick holds a B.A. in International Relations and has completed graduate studies in International Studies at Stanford University. He is a Senior Fellow at the UCLA School of Public Policy.
TransGlobal's resident scientists advise the company on specific technical issues related to new company development, turnaround analyses and investment due diligence.
Moshe Arditi, MD. Dr. Arditi is the Director of Pediatric Infectious Disease at Cedars-Sinai Medical Center and Associate Professor of Pediatrics at UCLA. Dr. Arditi's expertise covers infectious diseases, vaccinations and medical genetics. He received his MD from Istanbul University in Turkey. He was a Research Assistant at Yale University School of Medicine, Intern and Resident at University of Chicago School of Medicine and Postdoctoral Fellow at Northwestern University's Children's Memorial Hospital. In addition to his teaching position at UCLA, Dr. Arditi held various teaching appointments at Northwestern University School of Medicine and University of Southern California School of Medicine. He currently holds the following national and international committee appointments: Bacteriology & Mycology Study Section 1, Ad Hoc Member, National Institutes of Allergy & Infectious Diseases; As Hoc Research Grant reviewer, Swiss National Science Foundation; Ad Hoc Research Grant reviewer, Thrasher Research Fund; Program and Meetings Committee, Pediatric Infectious Diseases Society; and Antibiotics Utilization Review Committee, Cedars-Sinai Medical Center and UCLA School of Medicine. Dr. Arditi is an Associate Editor for the Journal of Immunology and the Journal of Endotoxin Research. He is also an ad hoc reviewer for the Journal of Infectious Diseases; Arteriosclerosis, Thrombosis and Vascular Biology; The Pediatric infectious Disease Journal; Clinical Infectious Diseases; Microbial Pathogenesis; Journal of Leukocyte Biology; Pediatrics and International Immunology. He is a recipient of numerous awards, including Clinician Scientist Award of the American Heart Association, Greater Los Angeles Affiliate (1993-98), Clinician Investigator Award of the National Institute of Health (1994-97), First Independent Award of National Institute of Health (1996-2001). His advisory board memberships include Merck & Co.'s Anti-Microbial Agents and Vaccines Panel, Eli Lilly's Anti-Sepsis research Panel and Aventis Pasteur's Vaccine Research Panel. He actively involved in various research projects funded by National Institute of Health, Merck & Co. and Agouron Pharmaceuticals. He is the author of 36 original peer reviewed articles published in medical journals and has contributed to 11 books and manuscripts as an invited author. He has presented abstracts in 50 conferences; he was the invited speaker in 24 talks and seminars and chaired 5 national symposia.
Bulent Basol, PhD. Dr. Basol received his Ph.D. in solid-state electronics from UCLA in 1980. His dissertation topic was thin film CdTe solar cells. Until the end of 1984, he led the research team at Monosolar Inc. and developed the electroplated CdTe thin film solar cell technology. SOHIO/British Petroleum acquired this successful technology and its associated patents for commercialization. Dr. Basol co-founded International Solar Electric Technology (ISET) in 1985 and led the research and development activities of ISET until year 2000. During this period he acted as the P.I. of nearly 30 projects funded by DOE, NASA, DOD, DOC, California State and large corporations to the tune of $ 15 million. He developed vacuum-based and particle-coating-based technologies for CIS and CdTe film growth. Other innovations included a flexible CIS cell structure on Kapton that won an innovation award from NASA.
Basol was instrumental in the development of a novel copper electroplating
technology for integrated circuit interconnect applications by a
Silicon-Valley start-up company, NuTool, Inc. where he serves as a Board
member. NuTool's plating systems have been installed in the manufacturing
plants of some of the largest chip manufacturers of the world.
Dr. Basol has sixteen (16) issued and twenty-two (22) pending patents in the fields of photovoltaics ("PV") and copper plating technologies for semiconductor manufacturing industry. Dr. Basol served on the executive committees and program committees of numerous Institute of Electrical and Electronics Engineers PV symposiums during the last 12 years. He delivered invited lectures and tutorials at these conferences. He participated in many National Team activities as a leader or team member both for CdTe and CIS technologies. He has over seventy (70) publications.